ArticleDisease models & mechanisms2014

Modelling of a targeted nanotherapeutic 'stroma' to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt-β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson's disease.

Jing-Wei Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.